UF Joins Global Study Into Parkinson’s Onset and Progression
The University of Florida has been selected to join The Michael J. Fox Foundation’s landmark clinical study, the Parkinson’s Progression Markers Initiative (PPMI), a global project seeking to discover new insights into the onset and progression of Parkinson’s disease by studying people with and without the disease.
UF, UF Health Announce Gift and New $75 Million Initiative To Expand Norman Fixel Institute
The University of Florida and UF Health announced an additional $25 million gift from the Lauren and Lee Fixel Family Foundation aimed at improving the lives of patients across the globe through the continued expansion of the Norman Fixel Institute for Neurological Diseases at UF Health.
HIV Drug Shows Potential To Combat Genetic Form of Dystonia in Preclinical Study
A new UF study found that an FDA-approved medication to treat HIV restored multiple brain abnormalities in a mouse model of a genetic form of dystonia.
UF Neuroscientists Discover Biomarker With Potential To Aid Parkinson’s Diagnosis
University of Florida neuroscientists have developed a new assay, or test, to detect minute amounts of a protein called tyrosine hydroxylase in blood immune cells of Parkinson’s disease patients, a key finding to aid in the development of a blood test to help diagnose and guide treatment for the neurodegenerative disorder.
UF College of Medicine Announces Clinical Science and Basic Science Faculty Research Awards
Michael Okun, MD, and Jiang Bian, Ph.D., were recently announced as the winners of the 2021 College of Medicine Clinical Science Research Award and the UF College of Medicine Basic Science Research Award, respectively.
Is It Time for a New Image of Parkinson’s Disease?
In an article published in the journal JAMA Neurology, Dr. Melissa J Armstrong and Dr. Michael S Okun argue that it is ‘Time for a new image of Parkinson’s disease’ that more accurately reflects the varied experiences of the people with the condition.
The Patient Is the Sun – Michael Okun
Patients have greatly influenced Michael S. Okun, MD, in his life and in his work. As the executive director of the Norman Fixel... Read More
As Cases of Parkinson’s Disease Increase, Community Must Demand Funding, Change
The odds of a person developing Parkinson’s disease over a lifetime are 1 in 15. It is the fastest-growing neurodegenerative disease and... Read More
How Those Cancelled DBS Treatments Are Resuming
In a new Neurology Today article, Dr. Michael S. Okun, chair of University of Florida neurology and executive director of the Norman Fixel Institute for... Read More
